Viewing Study NCT04590235


Ignite Creation Date: 2025-12-24 @ 10:10 PM
Ignite Modification Date: 2025-12-25 @ 7:45 PM
Study NCT ID: NCT04590235
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-08
First Post: 2020-07-28
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study of Selumetinib in Chinese Paediatric and Adult Subjects With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas (PN)
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module